Hepatic Function Flashcards
(44 cards)
CHARACTERISTICS OF THE LIVER
• Portal circulation, 25% of cardiac output, gives liver the first choice on absorbed nutrients and toxic substances, higher concentrations of insulin and glucagon. The fenestrated endothelium permits passage of proteins, lipoproteins and chylomicron remnants. Hepatic artery provides oxygen.
REPLACEMENT of LIVER FUNCTIONS.
- Artificial Liver systems
- Liver transplant (from dead donors, genetically modified animals?)
- Partial liver transplant (from living donors)
- Portal hepatocyte colonization (from healthy donors, or self after genetic engineering, stem cells?)
Mechanisms of Blood Glucose Maintenance
- Storage of Glycogen
- Release of glucose from stored glycogen.
- Conversion of other sugars to glucose
- Gluconeogenesis
Storage of Glycogen
- Highly branched glycogen permits rapid mobilization
- Glycogen synthase needs primer: glycogenin
- Insulin does not affect glucose transport in liver
- Liver contains hexokinase (as other tissues)(km<0.l mM), but 80% of phosphorylation is catalyzed by liver-specific glucokinase, sensitive to glucose concentration (Km = 10 mM)
- Contrary to hexokinase, glucokinase is not inhibited by its product (Glc-6-P). Thus, in liver, phosphorylation limits uptake. Once glycogen particles are replenished, Glc-6-P is largely channeled into lipogenesis.
Release of glucose from stored glycogen.
• Glucose-6-phosphatase occurs only in liver and kidney. Because of its larger mass and glycogen content, release of glucose between meals is largely a liver function
• Contrary to muscle, in the dephosphorylated state Hepatic glycogen phosphorylase is not stimulated by AMP, but in the phosporylated state it is inhibited by glucose.
•
Glycogen storage diseases
- Type I (Von Gierke disease)
- Type II (Pompe’sdisease)
- Type III (Cori’s disease)
- Type IV (Andersen’s disease)
- Type V( McArdle’s disease)
- Type VI (Hers’disease)
- Type VII
- Type VIII
Type I (Von Gierke disease)
- Defective enzyme: Glucose-6-phosphatase
- Organs affected: Liver and Kidney
- Clinical features: Large liver, fasting hypoglycemia
Type II (Pompe’sdisease)
- Defective enzyme: Lysosomal amylase
- Organs affected: All organs
- Clinical features: Cardiorespiratory failure before 2
Type III (Cori’s disease)
- Defective enzyme: Debranching enzyme
- Organs affected: Muscle , Liver
- Clinical features: Like Type I but milder course
Type IV (Andersen’s disease)
- Defective enzyme: Debranching enzyme
- Organs affected: Liver
- Clinical features: Cirrhosis: death before 2yrs
Type V( McArdle’s disease)
- Defective enzyme: Glycogen phosphorylase
- Organs affected: Muscle
- Clinical features: Cramps after exercise
Type VI (Hers’disease)
- Defective enzyme: Glycogen phosphorylase
- Organs affected: Liver
- Clinical features: Like Type I but milder course
Type VII
- Defective enzyme: Phosphofructokinase I
- Organs affected: Muscle
- Clinical features: Like Type V but milder
Type VIII
- Defective enzyme: Phosphorylase kinase
- Organs affected: Liver
- Clinical features: Mild liver enlargment; mild hypoglycemia
Conversion of other sugars to glucose.
Galactose
• Galactose is half of the carbohydrates in milk
• Conversion of Galactose to glucose:
Galactose -(1)-> Gal-1 P -(2)-> Glucose-1 P -(3)-> Glucose-6 P
1) Gal kinase
2) P-gal uridyl transferase
3) Epimerase
• Genetic deficiency of P-gal uridyl transferase is far more serious than Gal kinase because of accumulation of Gal-1 P which is toxic because of possible sequestration of intracellular Pi
Conversion of other sugars to glucose.
Fructose
• Fructose can be up to l/3 of total dietary carbohydrates, most as part of sucrose
• A minor portion of that fructose is used by muscle and liver through hexokinase via fructose-6 P and the normal glycolytic pathway
Fructose -(hexokinase)-> fructose-6 P
• The majority is converted to Glyceraldehyde:
Fructose -(1)-> Fructose-1 P -(2)-> Glyceraldehyde
1) Fructokinase
2) Fructose-1-P aldolase
• Genetic deficiency of Fructose-1-P aldolase is far more serious than Fructose kinase because of accumulation of Fructose-1 P which is toxic because of possible sequestration of intracellular Pi
Two Warnings about Fructose
One
Ingestion of excessive amounts of fructose (say, children drinking lots of apple cider in a hot summer day) can cause diarrhea because the absorption of fructose through the GLUT5 transporter is not very effective. This characteristic may be a protective mechanism, because excessive absorption of fructose could be damaging to the liver
Two Warnings about Fructose
Two
- Decades ago, it had been fashionable in some countries to consider replacing glucose by fructose as an intravenous nutrient in diabetics. Never do that!
- Large amounts of fructose are preferentially taken up by hepatocytes. Fructokinase, however, is a much more efficient enzyme than fructose-1-P aldolase even when this enzyme is not defective. That makes fructose-1-P aldolase rate-limiting. The consequence of the excessive uptake of fructose is the hepatic accumulation of fructose-1-P, which is deleterious to the liver (just as with much smaller amounts of fructose, when there is a genetic defect in fructose-1-P aldolase)
Gluconeogenesis
• Glucosw can be made in liver from non-sugar substrates, such as:
1) lactate
2) amino acids
3) glycerol.
• In the postabsorptive state, gluconeogenesis from lactate in the ‘Cori Cycle’, generates about 15% of liver glucose production (increased during anaerobic exercise).
• Gluconeogenesis from amino acids, is only 10% of liver glucose production in postabsorptive conditions, but it is vastly increased after a protein-rich meal (the only source of carbohydrates in carnivorous diets) or during starvation (in which case 50% is from alanine)
Gluconeogenesis
Regulation
- Availability of lactate (anaerobic exercise) or excess amino acids (after a protein-rich meal or because of net proteolysis in liver and muscle during starvation).
- Modulation by cAMP of pyruvate kinase and of the conversion of Frc-l,6 P to Frc-6 P (via Frc-2,6 P )
Gluconeogenesis and Starvation
- After several days of starvation, hepatic capacity for gluconeogenesis is increased by induction of PEP carboxykinase, glucose-6 phosphatase and many transaminases (by glucocorticoids and the release of the inhibitory effect of insulin through FOXO1 phosphorylation).
- Gluconeogenesis depends on the availability of cytosolic NAD+ for the reoxidation of malate.
- Combination of starvation and ethanol is a frequent cause of hypoglycemia because cytosolic oxidation of ethanol leads to fully reduced cytosolic NADH. Because of competition for the same cytosolic NAD+, starvation decreases ethanol metabolism, ethanol plus starvation leads to production of lactic acid, and ethanol inhibits liver glycolysis.
NITROGEN METABOLISM.
Synthesis of urea
Increased urea synthesis results from increased supply of amino acids to the liver (from the diet after a protein-rich meal, from muscle protein degradation during starvation). Increased Glu results in an expansion of intramitochondrial N-ac-Glu, which stimulates carbamyl-P synthetase. Over a period of days liver adapts to protein-rich diets or starvation with induction of all urea cycle enzymes (re: Dr Barlowe). Liver failure or defects in any of the urea cycle enzymes may result in high blood NH3, which is toxic to the brain.
NITROGEN METABOLISM.
Catabolism of excess dietary amino acids
Amino acid carbons in excess are used for glucogenesis, lipogenesis or ketogenesis depending on the condition and the nature of the C chain.
NITROGEN METABOLISM.
Conversion of extrahepatic amino acid C to glucose in the postabsorptive state
In this state, excess amino acids are generated primarily in muscle by autophagy. The branched chained amino acids (Leu, Ile, Val) are oxidized in muscle . Their amino N is transferred to pyruvate to make alanine (Ala). Ultimately, Ala transports C (from muscle glycolysis) and amino acids N to the liver, where it is converted to glucose and urea.